ORPH.L Share News (ORPH)

ORPH.L Information

There is currently no data for ORPH

IN BRIEF: Open Orphan denies any involvement in insider trading claim

Thu, 15th Sep 2022 13:02

Open Orphan PLC - London-based research organisation testing infectious and respiratory disease products - Confirms that it is helping the relevant Irish authorities with an allegation of potential insider trading dealing in the company's shares in 2020. Open Orphan says trading in the company's shares was undertaken by an "unconnected private individual". It said "there are no implications for the company in the resolution of this allegation and confirms that no employee, executive, director or anyone connected with the company had any involvement whatsoever in this matter nor are they suspected of any wrongdoing."

Current stock price: 9.67 pence, up 9.8%

12-month change: down 61%

By Chris Dorrell; chrisdorrell@alliancenews.com

More News

15 Nov 2021 11:32

Open Orphan subsidiary secures contract renewal with 'major' pharmaceutical client

(Sharecast News) - Contract research organisation Open Orphan said on Monday that its Venn Life Sciences subsidiary had signed a contract renewal with an unnamed "major global pharmaceutical client" worth £1.5m over a two-year period.

13 Oct 2021 13:25

EXECUTIVE CHANGES: Halfords hires CFO; new Pendragon, Versarien chairs

20 Sep 2021 14:30

Open Orphan signs £5.7m contract with biotech specialist

(Sharecast News) - Clinical research organisation Open Orphan announced on Monday that its subsidiary hVIVO has signed a £5.7m contract with a specialist biotechnology company developing therapeutics for respiratory viral infections, to test its antiviral product using the hVIVO Influenza human challenge study model.

20 Sep 2021 12:02